Biomarker Research (Feb 2025)
Correction: MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer
- Xin-Yi Sui,
- Shuo-Wen Cao,
- Xiao-Qing Song,
- Xi-Yu Liu,
- Chao Chen,
- Qingya Yan,
- Zhi-Qing Wang,
- Wen-Juan Zhang,
- Lin-Xiaoxi Ma,
- Xi Jin,
- Ding Ma,
- Yi Xiao,
- Song-Yang Wu,
- Ying Xu,
- Zhi-Ming Shao,
- Lei Fan
Affiliations
- Xin-Yi Sui
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Shuo-Wen Cao
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Xiao-Qing Song
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Xi-Yu Liu
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Chao Chen
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Qingya Yan
- School of Basic Medical Sciences, Xinxiang Medical University
- Zhi-Qing Wang
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Wen-Juan Zhang
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Lin-Xiaoxi Ma
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Xi Jin
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Ding Ma
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Yi Xiao
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Song-Yang Wu
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Ying Xu
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Zhi-Ming Shao
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- Lei Fan
- Department of Breast Surgery, Fudan University Shanghai Cancer Center
- DOI
- https://doi.org/10.1186/s40364-025-00743-9
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
